Tremor in the newborn infant caused by maternal smokingMARTHINSEN, L; UGES, D. R. A.Therapeutic drug monitoring. 2002, Vol 24, Num 3, issn 0163-4356, p. 455Article

PH adjustment of human blood plasma prior to bioanalytical sample preparationHENDRIKS, G; UGES, D. R. A; FRANKE, J. P et al.Journal of pharmaceutical and biomedical analysis. 2008, Vol 47, Num 1, pp 126-133, issn 0731-7085, 8 p.Article

Reconsideration of sample pH adjustment in bioanalytical liquid-liquid extraction of ionisable compoundsHENDRIKS, G; UGES, D. R. A; FRANKE, J. P et al.Journal of chromatography. B. 2007, Vol 853, Num 1-2, pp 234-241, issn 1570-0232, 8 p.Article

New practical algorithm for modelling retention times in gradient reversed-phase high-performance liquid chromatographyHENDRIKS, G; FRANKE, J. P; UGES, D. R. A et al.Journal of chromatography. 2005, Vol 1089, Num 1-2, pp 193-202, issn 0021-9673, 10 p.Article

New practical algorithm for modelling analyte recovery in bioanalytical reversed phase and mixed-mode solid phase extractionHENDRIKS, G; UGES, D. R. A; FRANKE, J. P et al.Journal of pharmaceutical and biomedical analysis. 2008, Vol 48, Num 1, pp 158-170, issn 0731-7085, 13 p.Article

Validity and reliability of self-reported exposure to environmental tobacco smoke in work officesWILLEMSEN, M. C; BRUG, J; UGES, D. R. A et al.Journal of occupational and environmental medicine. 1997, Vol 39, Num 11, pp 1111-1114, issn 1076-2752Article

Pitfalls in TDM of antibiotic drugs : Analytical and modelling issuesNEEF, C; TOUW, D. J; HARTEVELD, A. R et al.Therapeutic drug monitoring. 2006, Vol 28, Num 5, pp 686-689, issn 0163-4356, 4 p.Article

Pharmacokinetics of high-dose oral and intravenous dexamethasoneTOTH, G. G; KLOOSTERMAN, C; UGES, D. R. A et al.Therapeutic drug monitoring. 1999, Vol 21, Num 5, pp 532-535, issn 0163-4356Article

Impairment of organ function after oral ingestion of refined petrolJANSSEN, S; VAN DER GEEST, S; MEIJER, S et al.Intensive care medicine (Print). 1988, Vol 14, Num 3, pp 238-240, issn 0342-4642Article

Reduced 5-FU clearance in a patient with low DPD activity due to heterozygosity for a mutant allele of the DPYD geneMARING, J. G; VAN KUILENBURG, A. B. P; HAASJES, J et al.British journal of cancer. 2002, Vol 86, Num 7, pp 1028-1033, issn 0007-0920Article

Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell linesVAN WAARDENBURG, R. C. A. M; PRINS, J; MEIJER, C et al.Anticancer research. 1996, Vol 16, Num 4A, pp 1963-1970, issn 0250-7005Article

Continuous carboplatin infusion during 6 weeks' radiotherapy in locally inoperable non-small-cell lung cancer : a phase I and pharmacokinetic studyGROEN, H. J. M; VAN DER LEEST, A. H. D; DE VRIES, E. G. E et al.British journal of cancer. 1995, Vol 72, Num 4, pp 992-997, issn 0007-0920Article

Continuous infusion of ceftazidime in febrile neutropenic patients with acute myeloid leukemiaDAENEN, S; ERJAVEC, Z; UGES, D. R. A et al.European journal of clinical microbiology & infectious diseases (Print). 1995, Vol 14, Num 3, pp 188-192, issn 0934-9723Article

Sensitive method for the determination of vincristine in human serum by high-performance liquid chromatography after on-line column-extractionBLOEMHOF, H; VAN DIJK, K. N; DE GRAAF, S. S. N et al.Journal of chromatography. Biomedical applications. 1991, Vol 572, Num 1-2, pp 171-179, issn 0378-4347Article

Influence of docosahexaenoic acid on cisplatin resistance in a human small cell lung carcinoma cell lineTIMMER-BOSSCHA, H; HOSPERS, G. A. P; MEIJER, C et al.Journal of the National Cancer Institute. 1989, Vol 81, Num 14, pp 1069-1075, issn 0027-8874Article

Renal dysfunction following high-dose carboplatin treatmentMULDER, P. O. M; SLEIJFER, D. T; DE VRIES, E. G. E et al.Journal of cancer research and clinical oncology. 1988, Vol 114, Num 2, pp 212-214, issn 0171-5216Article

Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Linezolid in Patients with Multidrug-Resistant TuberculosisVU, D. H; BOLHUIS, M. S; KOSTER, R. A et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 11, pp 5758-5763, issn 0066-4804, 6 p.Article

Dried Blood Spots: A New Tool for Tuberculosis Treatment OptimizationVU, D. H; ALFFENAAR, J. W. C; EDELBROEK, P. M et al.Current pharmaceutical design (Print). 2011, Vol 17, Num 27, pp 2931-2939, issn 1381-6128, 9 p.Article

Vincristine in childhood leukaemia: no pharmacokinetic rationale for dose reduction in adolescentsFROST, B-M; LÖNNERHOLM, G; KOOPMANS, P et al.Acta paediatrica (Oslo). 2003, Vol 92, Num 5, pp 551-557, issn 0803-5253, 7 p.Article

A phase I study of a new polyamine biosynthesis inhibitor, SAM486A, in cancer patients with solid tumoursPARIDAENS, R; UGES, D. R. A; CAPDEVILLE, R et al.British journal of cancer. 2000, Vol 83, Num 5, pp 594-601, issn 0007-0920Article

A prolonged methoxymorpholino doxorubicin (PNU-152243 or MMRDX) infusion schedule in patients with solid tumours : a phase 1 and pharmacokinetic studyFOKKEMA, E; VERWEIJ, J; VAN OOSTEROM, A. T et al.British journal of cancer. 2000, Vol 82, Num 4, pp 767-771, issn 0007-0920Article

Vincristine pharmacokinetics after repetitive dosing in childrenGIDDING, C. E. M; MEEUWSEN-DE BOER, G. J; KOOPMANS, P et al.Cancer chemotherapy and pharmacology. 1999, Vol 44, Num 3, pp 203-209, issn 0344-5704Article

Differential expression of DNA topoisomerase IIα and -β in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC₄WITHOFF, S; DE VRIES, E. G. E; KEITH, W. N et al.British journal of cancer. 1996, Vol 74, Num 12, pp 1869-1876, issn 0007-0920Article

A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 daysGIETEMA, J. A; DE VRIES, E. G. E; SLEIJFER, D. T et al.British journal of cancer. 1993, Vol 67, Num 2, pp 396-401, issn 0007-0920Article

The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell lineMEIJER, C; MULDER, N. H; HOSPERS, G. A. P et al.British journal of cancer. 1990, Vol 62, Num 1, pp 72-77, issn 0007-0920, 6 p.Article